Under construction – not a live service
Sign in
Taking people in TaiwanNo phase

Tracks brain small vessel disease with genetic and MRI testing

Follows people with small vessel brain disease, using genetic testing and MRI scans.

Plain-language title generated from the registry record
Registry title: Taiwan Associated Genetic and Nongenetic Small Vessel Disease

Key facts

Where
Taipei, TaiwanSee the site

Where in Taiwan

  • Department of Neurology, National Taiwan University HospitalTaipei, TaiwanTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
National Taiwan University Hospital
Trial code
NCT05473637
Record updated
20 January 2026
Original description
The TAG-SVD enrolled patients with clinical and neuroimaging features of cerebral small vessel disease (CSVD). All enrolled patients will receive next-generation sequence (NGS) with probes designed to target five candidate CSVD genes, and patients will be divided into genetic or non-genetic groups accordingly. Their clinical features and outcome will be followed for at least 2 years.Read full original descriptionShow less

Deciphering, Construction and Validation of Magnetic Resonance Imaging Maps, Clinical Features and Outcomes in Genetic and Nongenetic Cerebral Small Vessel Diseases

The TAG-SVD enrolled patients with clinical and neuroimaging features of cerebral small vessel disease (CSVD). All enrolled patients will receive next-generation sequence (NGS) with probes designed to target five candidate CSVD genes, and patients will be divided into genetic or non-genetic groups accordingly. Their clinical features and outcome will be followed for at least 2 years.

Inclusion: Participants must have at least one of the following symptoms/signs or history; stroke (especially small vessel occlusion type of ischaemic stroke, spontaneous ICH or young stroke); cognitive impairment or dementia; gait disturbance; parkinsonism (especially vascular parkinsonism features); headache (especially migraine); positive family history of hereditary CSVD; MRI evidence of CSVD (MRI may be done for other reasons), including mild to moderate white matter hyper intensity, any lacune, or any cerebral microbleed.

Exclusion: MRI evidence of CSVD due to other inflammatory, malignancy, or structural lesions; patients or family members not willing to sign informed consent.

ClinicalTrials.gov NCT05473637